In September of 2019, Purdue Pharma LP filed for Chapter 11 protection after facing a wave of lawsuits over its opioid painkiller drug, OxyContin. The Sackler family, who own the pharmaceutical company, have attempted to use a controversial tactic to get bankruptcy-like protections to without filing for bankruptcy in order to protect their personal assets and holdings. On Wednesday, June 15th, according to Bloomberg, “U.S. Bankruptcy Judge Robert Drain approved an investigation into whether the drugmaker’s owners, members of the billionaire Sackler family, have had undue influence on an independent committee of Purdue board members,” a win for the advocacy group of parents whose children died as a result of opioid abuse. Professor Jonathan Lipson, Harold E. Kohn Chair and Professor of Law at Temple Law School, was of counsel to the movant. His colleague, Professor Melissa Jacoby, Graham Kenan Professor of Law at the University of North Carolina at Chapel Hill, put the ruling into context.  Temple Law School: In in the June 15th ruling, Judge Drain approved an investigation, which will give an …